Conjugated Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change
New York, Dec. 18, 2020 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Conjugated Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change - https://www.reportlinker.com/p05998722/?utm source=GNW and Spectrum Pharmaceuticals Inc.
The global conjugated monoclonal antibodies market is expected to decline from $8.35 billion in 2019 to $8.15 billion in 2020 at a compound annual growth rate (CAGR) of -2.36%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $10.41 billion in 2023 at a CAGR of 8.49%.
Chemical Pharmaceutical Market to Witness Significant openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.